Home  ›  Germany  ›  SCHOTT Pharma AG & Co KGaA

SCHOTT Pharma AG & Co KGaA insider transactions

Healthcare · XETRA · Germany
Net insider signal · last quarter
Neutral
Share price & insider trades · last quarter▲ buy   ▼ sell
€ 22.1€ 12.910 Apr09 Jul

Insiders were net buyers over the last quarter — 0 buys against 0 sells — a net €0 of buying. Most recent filing: 12 Feb 2026.

Net insider flow · last quarter
+€00 buys · 0 sells
Insider profiles
+●.●% avg 3m · win rate

Transactions

DateInsiderRoleTypeValue
12 Feb 2026Reinhard MayerExecutive BoardBuy€50,655
11 Feb 2026Torsten DerrSupervisory BoardBuy€110,089
18 Dec 2025Reinhard MayerExecutive Board▲ Buy€44,779
Showing older filings · the 2 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at German-listed companies must disclose dealings in their company's shares to BaFin. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.